search icon
adil-img

Adial Pharmaceuticals Inc, Common Stock

ADIL

NAQ

$1.03

+$0.01

(0.98%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.60M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.71K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.30
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.77 L
$4.17 H
$1.03

About Adial Pharmaceuticals Inc, Common Stock

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameADILSectorS&P500
1-Week Return-4.67%0.21%-1.14%
1-Month Return-6.85%0.5%-4.04%
3-Month Return4.88%-9.53%-0.34%
6-Month Return-8.11%-5.25%3.71%
1-Year Return-31.54%0.23%22.63%
3-Year Return-98.44%4.42%25.29%
5-Year Return-98.26%35.84%77.92%
10-Year Return-98.99%100.52%190.49%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue565.00564.0055.11K60.50K564.00[{"date":"2019-12-31","value":0.93,"profit":true},{"date":"2020-12-31","value":0.93,"profit":true},{"date":"2021-12-31","value":91.08,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.93,"profit":true}]
Gross Profit(565.00)(564.00)(55.11K)(60.50K)(564.00)[{"date":"2019-12-31","value":-56500,"profit":false},{"date":"2020-12-31","value":-56400,"profit":false},{"date":"2021-12-31","value":-5510600,"profit":false},{"date":"2022-12-31","value":-6050100,"profit":false},{"date":"2023-12-31","value":-56400,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses8.24M10.93M17.74M13.32M6.89M[{"date":"2019-12-31","value":46.48,"profit":true},{"date":"2020-12-31","value":61.6,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":75.07,"profit":true},{"date":"2023-12-31","value":38.83,"profit":true}]
Operating Income(8.24M)(10.93M)(19.29M)(13.32M)(6.89M)[{"date":"2019-12-31","value":-824490000,"profit":false},{"date":"2020-12-31","value":-1092798500,"profit":false},{"date":"2021-12-31","value":-1928872300,"profit":false},{"date":"2022-12-31","value":-1331712700,"profit":false},{"date":"2023-12-31","value":-688794700,"profit":false}]
Total Non-Operating Income/Expense(251.29K)67.49K(1.82M)648.42K(7.70K)[{"date":"2019-12-31","value":-38.76,"profit":false},{"date":"2020-12-31","value":10.41,"profit":true},{"date":"2021-12-31","value":-280.15,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.19,"profit":false}]
Pre-Tax Income(8.59M)(10.89M)(19.52M)(12.73M)(7.00M)[{"date":"2019-12-31","value":-859142900,"profit":false},{"date":"2020-12-31","value":-1089299000,"profit":false},{"date":"2021-12-31","value":-1951740300,"profit":false},{"date":"2022-12-31","value":-1273191800,"profit":false},{"date":"2023-12-31","value":-700189000,"profit":false}]
Income Taxes441.76K(32.49K)(94.08K)(502.00)(1.88M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-7.36,"profit":false},{"date":"2021-12-31","value":-21.3,"profit":false},{"date":"2022-12-31","value":-0.11,"profit":false},{"date":"2023-12-31","value":-425.24,"profit":false}]
Income After Taxes(9.03M)(10.86M)(19.42M)(12.73M)(5.12M)[{"date":"2019-12-31","value":-903319200,"profit":false},{"date":"2020-12-31","value":-1086049500,"profit":false},{"date":"2021-12-31","value":-1942332600,"profit":false},{"date":"2022-12-31","value":-1273141600,"profit":false},{"date":"2023-12-31","value":-512334100,"profit":false}]
Income From Continuous Operations(8.59M)(10.89M)(19.42M)(12.73M)(9.58M)[{"date":"2019-12-31","value":-859142900,"profit":false},{"date":"2020-12-31","value":-1089299000,"profit":false},{"date":"2021-12-31","value":-1942332600,"profit":false},{"date":"2022-12-31","value":-1273141600,"profit":false},{"date":"2023-12-31","value":-958240600,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(8.59M)(10.86M)(19.42M)(12.73M)(7.00M)[{"date":"2019-12-31","value":-859142900,"profit":false},{"date":"2020-12-31","value":-1086049500,"profit":false},{"date":"2021-12-31","value":-1942332600,"profit":false},{"date":"2022-12-31","value":-1273141600,"profit":false},{"date":"2023-12-31","value":-700189000,"profit":false}]
EPS (Diluted)(0.84)(0.86)(1.05)(0.52)(1.68)[{"date":"2019-12-31","value":-84,"profit":false},{"date":"2020-12-31","value":-86,"profit":false},{"date":"2021-12-31","value":-105,"profit":false},{"date":"2022-12-31","value":-51.5,"profit":false},{"date":"2023-12-31","value":-168,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ADIL
Cash Ratio 6.28
Current Ratio 6.78

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ADIL
ROA (LTM) -104.18%
ROE (LTM) -320.96%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ADIL
Debt Ratio Lower is generally better. Negative is bad. 0.12
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.88

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ADIL
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.11
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Adial Pharmaceuticals Inc share price today?

Adial Pharmaceuticals Inc (ADIL) share price today is $1.03

Can Indians buy Adial Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Adial Pharmaceuticals Inc (ADIL) on Vested. To buy Adial Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ADIL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Adial Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Adial Pharmaceuticals Inc (ADIL) via the Vested app. You can start investing in Adial Pharmaceuticals Inc (ADIL) with a minimum investment of $1.

How to invest in Adial Pharmaceuticals Inc shares from India?

You can invest in shares of Adial Pharmaceuticals Inc (ADIL) via Vested in three simple steps:

  • Click on Sign Up or Invest in ADIL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Adial Pharmaceuticals Inc shares
What is Adial Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Adial Pharmaceuticals Inc (ADIL) is $4.17. The 52-week low price of Adial Pharmaceuticals Inc (ADIL) is $0.77.

What is Adial Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Adial Pharmaceuticals Inc (ADIL) is

What is Adial Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Adial Pharmaceuticals Inc (ADIL) is 1.11

What is Adial Pharmaceuticals Inc dividend yield?

The dividend yield of Adial Pharmaceuticals Inc (ADIL) is 0.00%

What is the Market Cap of Adial Pharmaceuticals Inc?

The market capitalization of Adial Pharmaceuticals Inc (ADIL) is $6.60M

What is Adial Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Adial Pharmaceuticals Inc is ADIL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top